(Q73832413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Calcium channel agonists and dystonia in the mouse (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

H A Jinnah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J P Sepkuty

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Ho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Yitta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Drew

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J D Rothstein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E J Hess

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

542-551

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10830422%20AND%20SRC:MED&resulttype=core&format=json

Tolcapone: COMT inhibition for the treatment of Parkinson's disease

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

The anatomical basis of symptomatic hemidystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

The pathophysiology of primary dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Research opportunities in dystonia: National Institute of Neurological Disorders and Stroke workshop summary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

CLINICAL AND PATHOLOGICAL STUDIES OF AN HEREDITARY NEUROPATHY IN MICE (DYSTONIA MUSCULORUM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Pathology of idiopathic dystonia: findings from genetic animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Dystonia associated with mutation of the neuronal sodium channel Scn8a and identification of the modifier locus Scnm1 on mouse chromosome 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

21 January 2018

Calcium channel ligands

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Bay K 8644 induces a reversible spasticity-like syndrome in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Enantiomer selectivity and the development of tolerance to the behavioral effects of the calcium channel activator BAY K 8644

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY k 8644

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-Amphetamine and apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Calcium channel activation and self-biting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Anticonvulsant effects of some calcium entry blockers in DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Calcium channels in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Ion channel mutations affecting muscle and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Structure and function of voltage-gated ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Antidystonic effects of L-type Ca2+ channel antagonists in a hamster model of idiopathic dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Treatment of persistent myoclonic tardive dystonia with verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Cinnarizine-induced parkinsonism: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Diltiazem-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Parkinsonism induced by amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Movement disorders and depression due to flunarizine and cinnarizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

Parkinsonism associated with calcium channel blockers: a prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200005%2915%3A3%3C542%3A%3AAID-MDS1019%3E3.0.CO%3B2-2

10.1002/1531-8257(200005)15:3<542::AID-MDS1019>3.0.CO;2-2

21 January 2018

Identifiers

DOI

0 references

1 reference